Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combined modalities for nucleosides and/or NADPH oxidase (NOX) inhibitors as myeloid-specific antiviral agents

Combined modalities for nucleosides and/or NADPH oxidase (NOX) inhibitors as myeloid-specific antiviral agents

US Patent 12239655 · Granted Mar 4, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antiviral JAK inhibitors useful in treating or preventing retroviral and other v2025
Antiviral JAK inhibitors useful in treating or preventing retroviral and other v2025
Modulators of orphan nuclear receptors for NASH and other metabolic disorders2025
Modulators of orphan nuclear receptors for NASH and other metabolic disorders2025
Modulators of orphan nuclear receptors for NASH and other metabolic disorders2025
Peptidomimetics for the treatment of coronavirus and picorna virus infections2025
Peptidomimetics for the treatment of coronavirus and picorna virus infections2025
Use of TREM-1 inhibitors for treatment, elimination and eradication of HIV-1 inf2024
Use of TREM-1 inhibitors for treatment, elimination and eradication of HIV-1 inf2024
Antiviral agents and nucleoside analogs for treatment of Zika virus2024
Antiviral agents and nucleoside analogs for treatment of Zika virus2024
Antiviral agents and nucleoside analogs for treatment of Zika virus2024